A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin
Clinical trial NCT01570751 · COMPLETED
Trial details
- NCT number
- NCT01570751
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2014-01-01
- Enrollment
- 145
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.